UpHealth, Inc. (UPHLW) Financial Statements (2024 and earlier)

Company Profile

Business Address 14000 S. MILITARY TRAIL
DELRAY BEACH, FL 33484
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 80 - Health Services (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,5483,34246,80313,33315,55722,608
Cash and cash equivalents2,5483,34246,80313,33315,55722,608
Restricted cash and investments      
Receivables 14,66516,52722,36924,43221,86522,647
Inventory, net of allowances, customer advances and progress billings   181341612,762
Inventory   181341612,762
Disposal group, including discontinued operation    3,1782,991 
Other undisclosed current assets2,9962,1402,1213,2632,7484,077
Total current assets:20,20922,00971,31144,34043,32252,094
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization     5,916 
Operating lease, right-of-use asset1,9021,6535,7286,6447,213 
Property, plant and equipment  10,22813,99714,324 20,075
Long-term investments and receivables96,76896,76821,20021,20021,20021,200
Long-term investments96,76896,76821,20021,20021,20021,200
Intangible assets, net (including goodwill) 103,027103,993182,387189,891191,037251,502
Goodwill 80,31080,310153,318159,675159,675195,028
Intangible assets, net (excluding goodwill) 22,71723,68329,06930,21631,36256,474
Disposal group, including discontinued operation, noncurrent assets    61,92462,525 
Deferred income tax assets      83
Other noncurrent assets375493455474438454
Other undisclosed noncurrent assets9,527   8,153 
Total noncurrent assets:211,599213,135223,767294,457296,482293,314
TOTAL ASSETS:231,808235,144295,078338,797339,804345,408
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities22,31316,21951,69658,36056,74666,227
Interest and dividends payable2,971
Taxes payable229
Employee-related liabilities5,396
Accounts payable11,7235,18712,69417,26117,98316,393
Accrued liabilities10,59011,03239,00241,09938,76341,238
Deferred revenue 48522,5121,5492,7384,407
Debt 143,8893,1272,9363,02310
Disposal group, including discontinued operation    2,9753,319 
Other liabilities   453433743,758
Due to related parties366229 
Other undisclosed current liabilities4,4706,2082,1952,7482,840(7,755)
Total current liabilities:26,831166,36859,98369,36768,96966,647
Noncurrent Liabilities
Long-term debt and lease obligation146,524 143,273151,434148,938143,303
Long-term debt, excluding current maturities146,524 141,255148,621145,962143,303
Finance lease, liability   2,0182,8132,976 
Liabilities, other than long-term debt761,3496,40714,38015,7513,915
Deferred income tax liabilities  1,2021,2021,2031,200 
Due to related parties31281343
Disposal group, including discontinued operation, liabilities    7,6787,787 
Other liabilities761472762016622,880
Operating lease, liability   4,9295,2375,765 
Derivative instruments and hedges, liabilities    3056692
Other undisclosed noncurrent liabilities3,2733,297 17961
Total noncurrent liabilities:149,8734,646149,680165,831164,698147,279
Total liabilities:176,704171,014209,663235,198233,667213,926
Equity
Equity, attributable to parent55,10464,13084,137102,206105,148130,666
Common stock222222
Treasury stock, value(17,000)(17,000)(17,000)(17,000)(17,000)(17,000)
Additional paid in capital696,150695,152694,554693,496688,355686,518
Accumulated deficit(624,048)(614,024)(593,419)(574,292)(566,209)(538,854)
Equity, attributable to noncontrolling interest   1,2781,393989816
Total equity:55,10464,13085,415103,599106,137131,482
TOTAL LIABILITIES AND EQUITY:231,808235,144295,078338,797339,804345,408

Income Statement (P&L) ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
Revenues 17,34932,68137,82342,14540,49738,666
Cost of revenue
(Cost of Goods and Services Sold)
 (8,029)(15,058)(17,847)(19,469)(26,538)(20,167)
Gross profit: 9,32017,62319,97622,67613,95918,499
Operating expenses(14,583)(90,412)(30,718)(23,454)(27,365)(138,531)
Operating loss:(5,263)(72,789)(10,742)(778)(13,406)(120,032)
Nonoperating income (expense)(6,846)52,651(7,010)(6,857)(5,415)(58,771)
Investment income, nonoperating  59,065(29)26636(37,485)
Interest and debt expense(7,492)(6,709)(7,136)(6,858) (14,610)
Other undisclosed income from continuing operations before equity method investments, income taxes      14,610
Loss from continuing operations before equity method investments, income taxes:(19,601)(26,847)(24,888)(14,493)(18,821)(178,803)
Other undisclosed income from continuing operations before income taxes7,4926,7097,1366,858  
Loss from continuing operations before income taxes:(12,109)(20,138)(17,752)(7,635)(18,821)(178,803)
Income tax expense (benefit)2,085 (867) (8,360)13,219
Loss from continuing operations:(10,024)(20,138)(18,619)(7,635)(27,181)(165,584)
Loss before gain (loss) on sale of properties:(165,584)
Income from discontinued operations      
Net income (loss):(10,024)(20,138)(18,619)(7,635)(27,181)(165,584)
Net loss attributable to noncontrolling interest  (467)(508)(448)(174)(178)
Net income (loss) available to common stockholders, diluted:(10,024)(20,605)(19,127)(8,083)(27,355)(165,762)

Comprehensive Income ($ in thousands)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
Net income (loss):(10,024)(20,138)(18,619)(7,635)(27,181)(165,584)
Other undisclosed comprehensive income     7,659 
Comprehensive income (loss):(10,024)(20,138)(18,619)(7,635)(19,522)(165,584)
Comprehensive loss, net of tax, attributable to noncontrolling interest  (467)(508)(448)(174)(178)
Comprehensive income (loss), net of tax, attributable to parent:(10,024)(20,605)(19,127)(8,083)(19,696)(165,762)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: